Jim Shepard

Director at Arduro Sustainable Rubber
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Chemical Manufacturing
    • 1 - 100 Employee
    • Director
      • May 2019 - Present

      Independant Director and Board Chair; Finance, Compensation and Executive Committees Arduro provides a sustainable, economic and environmentally friendly solution to disposing of waste tires (also known as end-of-life tires) through the reduction of the environmental footprint of traditionally toxic styrene-butadiene rubber and carbon black manufacturering. Arduro has developed a proprietary process that RECLAIMS and RETURNS waste tires into high-grade, valuable raw materials including: -Styrene-Butadiene Rubber ("Rubber"​) -Carbon Black -Scrap Steel -and other Chemicals used in the manufacturing of tires We believe this Creates a Circular Economy where waste products are RECLAIMED and RETURNED into their original uses or materials with a minimal environmental impact.

    • Director
      • Jul 2015 - Present

      Independant Director and Board Chair Spectral Platforms has developed tools for rapid diagnosis of infectious diseases in a clinical setting. These tools can characterize pathogen presence in 5 minutes (compared to current methods that take 24 hours), and characterize antimicrobial susceptibility/resistance information in 40 minutes (compared to current methods that take 48 hours). These Rapid tests can enhance the care of patients and save time and resources in that care. Independant Director and Board Chair Spectral Platforms has developed tools for rapid diagnosis of infectious diseases in a clinical setting. These tools can characterize pathogen presence in 5 minutes (compared to current methods that take 24 hours), and characterize antimicrobial susceptibility/resistance information in 40 minutes (compared to current methods that take 48 hours). These Rapid tests can enhance the care of patients and save time and resources in that care.

    • Founder and Managing Partner
      • 2006 - Present

      A next-generation private equity firm, built to deliver consistently high upside returns with low downside risk regardless of market cycles. By actively, strategically and operationally guiding the industrial B2B companies we invest in; in markets we understand from the inside out. Our management firm and first fund launched in 2006. Today we have over $1.5B AUM. As a private equity 3.0 firm, we invest in proven, industrial B2B companies in the middle market. Then assist in their operational transformation into great performers, as the best way to generate and sustain superior investor value in today's environment. Unlike firms that are generalist investors, and pure money managers who are hands-off, we're operating managers and industry insiders who are hands-on and specialized. Applying leading operational insights, strategies, skills and connections across the board to successfully buy, guide, grow and sell these industrial B2B companies. GenNx360 has a global team and presence, of 25 professionals. Coupled with a worldwide relationship network of top financial and operating executives. The Firm is a thought leader on building core enterprise value.

    • United States
    • Industrial Machinery Manufacturing
    • 700 & Above Employee
    • CEO and Company Officer
      • Jun 1978 - 2006

Education

  • University of Pennsylvania
    Master of Engineering (Systems Engineering)
    1978 - 1981
  • Princeton University
    Bachelor of Science (BS)
    1974 - 1978

Community

You need to have a working account to view this content. Click here to join now